24-month interim results from the first long-term study of SCS with automatic, objective, daily remote monitoring presented at NANS 2025 Annual Meeting This system integrates RESONANCE™ multiphase ...

At the recently concluded North American Neuromodulation Society annual meeting, Boston presented a total of 17 abstracts.

Abbott Park, Illinois Tuesday, January 27, 2026, 13:00 Hrs [IST] ...

Detailed price information for Autonomix Medical Inc (AMIX-Q) from The Globe and Mail including charting and trades.

Faced with chronic nerve pain, many people turn to cannabis-based medications, hoping for relief that conventional treatments ...

Transvascular energy ablation showed a 79% response rate in reducing pancreatic cancer pain without opioids. Patients experienced a mean pain reduction of 4.96 points, equating to a 66% improvement in ...

SereNeuro Therapeutics, a preclinical biotechnology company developing non-opioid pain therapies, has unveiled new data on a novel approach to chronic pain management and joint tissue preservation.

Clinical trial of LX9211, an investigational non-opioid investigational therapy, demonstrated clinically significant benefits for people with diabetic peripheral neuropathic pain (DPNP) Investigators ...

The new in vivo data, obtained in a rat model of osteoarthritis (OA) of the knee, show significant pain relief in both movement-induced and evoked pain as well as a significant anti-inflammatory ...

(RTTNews) - Silo Pharma, Inc. (SILO) on Tuesday announced positive early findings from its ongoing study evaluating the pharmacokinetics, safety, and tolerability of SP-26, a novel ketamine-based ...

PHILADELPHIA -- An oral, non-addictive sodium channel blocker safely relieved moderate-to-severe acute pain following surgery, according to phase III data that could support regulatory approval.

In the ongoing search to find a pain intervention that does away with the need for opioids – and bypasses drugs altogether – a new game-based system has shown huge promise in tackling chronic ...